Sara Taranto

The Ohio State University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index179citations21works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fibroblast Growth Factor Research(9), Multiple Myeloma Research and Treatments(7), Cancer, Hypoxia, and Metabolism(3), Mast cells and histamine(3), Cancer Mechanisms and Therapy(3)

Publications21 total

Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survival
Cell Death and Disease·2026Open Access
NEAT1: a multifaceted long non-coding RNA in multiple myeloma
Haematologica·2025Open Access
Corrigendum to “FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma” [Biomed. Pharmacother. 192 (2025) 118677]
Biomedicine & Pharmacotherapy·2025Open Access
FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma
Universität Zürich, ZORA·2025Open Access
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
Biomedicine & Pharmacotherapy·2025Open Access
CREB1 and TXNIP Regulate Autophagy and Unfolded Protein Response in Multiple Myeloma
Blood·2024Open Access
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Journal of Experimental & Clinical Cancer Research·2024· 10 citedOpen Access
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
Pharmacological Research·2024· 7 citedOpen Access
Supplementary Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
2023Open Access
Supplementary Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
2023Open Access
Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
2023Open Access
Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
2023Open Access
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
Cancer Letters·2021· 18 cited
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
Cancers·2021· 7 citedOpen Access
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
European Journal of Medicinal Chemistry·2021· 5 citedOpen Access
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
International Journal of Molecular Sciences·2020· 39 citedOpen Access
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
Cancer Research·2020· 51 citedOpen Access
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
International Journal of Molecular Sciences·2019· 4 citedOpen Access
Abstract C121: Long Pentraxin-3 modulates bladder cancer progression
Molecular Cancer Therapeutics·2019
Abstract C052: FGF trapping impairs multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress
Molecular Cancer Therapeutics·2019
page 1 of 2Next →

Frequent Co-authors

Arianna Giacomini(16), Roberto Ronca(15), Marco Presta(14), Elisabetta Grillo(10), Sara Matarazzo(10), Federica Maccarinelli(9), Aldo M. Roccaro(9), Antonio Sacco(8), Riccardo Castelli(8), Marco Mor(8), Annamaria Cattaneo(7), Gaia C. Ghedini(6), Silvia L. Locatelli(6), Eleonora Foglio(6), Vanessa Desantis(6), Nadia Cattane(6), Carmelo Carlo‐Stella(6), Giuseppe Paganini(5), Angelo Belotti(5), Sara Rezzola(5)